Boston Partners acquired a new stake in Varex Imaging Co. (NASDAQ:VREX – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 597,762 shares of the company’s stock, valued at approximately $8,718,000. Boston Partners owned approximately 1.45% of Varex Imaging at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in VREX. Isthmus Partners LLC increased its position in Varex Imaging by 0.8% during the fourth quarter. Isthmus Partners LLC now owns 149,874 shares of the company’s stock worth $2,187,000 after acquiring an additional 1,260 shares during the period. Intech Investment Management LLC grew its position in shares of Varex Imaging by 13.7% during the 3rd quarter. Intech Investment Management LLC now owns 16,267 shares of the company’s stock worth $194,000 after purchasing an additional 1,959 shares in the last quarter. Inspire Advisors LLC increased its holdings in shares of Varex Imaging by 22.5% during the fourth quarter. Inspire Advisors LLC now owns 17,334 shares of the company’s stock worth $253,000 after purchasing an additional 3,185 shares during the period. Quest Partners LLC acquired a new stake in shares of Varex Imaging in the third quarter valued at approximately $41,000. Finally, New York State Common Retirement Fund boosted its stake in shares of Varex Imaging by 60.7% in the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company’s stock valued at $139,000 after buying an additional 3,600 shares during the period.
Varex Imaging Trading Down 1.2 %
Shares of VREX stock opened at $12.86 on Friday. Varex Imaging Co. has a fifty-two week low of $10.19 and a fifty-two week high of $18.30. The stock’s fifty day moving average price is $13.29 and its two-hundred day moving average price is $13.41. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36. The company has a market cap of $529.83 million, a PE ratio of -10.99 and a beta of 0.56.
Analyst Upgrades and Downgrades
VREX has been the topic of a number of recent research reports. Oppenheimer lowered their price objective on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research note on Friday, February 7th. B. Riley reaffirmed a “buy” rating and issued a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th. Finally, StockNews.com upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th.
View Our Latest Analysis on VREX
Varex Imaging Company Profile
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Read More
- Five stocks we like better than Varex Imaging
- How to Buy Cheap Stocks Step by Step
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Expert Stock Trading Psychology Tips
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.